The widespread use of peptide receptor radionuclide therapy (PRRT) represents a major
therapeutic breakthrough in nuclear medicine, particularly since the introduction of 177Lu …

A multidisciplinary approach to the work up and management of pulmonary carcinoid tumors and
DIPNECH: a narrative review - PMC Back to Top Skip to main content NIH NLM Logo Access …

Background Peptide receptor radionuclide therapy (PRRT) is one of the most promising
therapeutic strategies in neuroendocrine neoplasms (NENs). Nevertheless, its role in certain …

Neuroendocrine neoplasms (NENs) encompass a broad spectrum of tumors throughout the
body and range in biologic behavior from indolent to aggressive. Consequently, a wide …

Purpose: In this study, DOTA-IBA was radiolabeled with 68Ga and we determined the
optimum labelling conditions and assessed the biological properties of 68Ga-DOTA-IBA. We …

Simple Summary Bronchial carcinoids (BCs) are uncommon and usually slow growing
neuroendocrine epithelial malignancies that represent less than 2% of all lung cancers …

Neuroendocrine neoplasia (NEN) is an umbrella term that includes a widely heterogeneous
disease group including well-differentiated neuroendocrine tumours (NETs), and aggressive …

Simple Summary Peptide receptor radionuclide therapy (PRRT) is a systemic treatment
consisting of the administration of a tumor-targeting radiopharmaceutical into the circulation …

Precision medicine is playing a pivotal role in strategies of cancer therapy. Unlike
conventional one-size-fits-all chemotherapy or radiotherapy modalities, precision medicine …

Neuroendocrine neoplasms (NEN) are rare and heterogeneous tumors, originating mostly
from the gastro-entero-pancreatic (GEP) tract followed by the lungs. Multidisciplinary …